Preliminary Agenda*
Friday, May 3, 2013 |
|||
7:00 am - 8:00 am |
|
Breakfast/Product Theater - An Overview of Kyprolis® (carfilzomib) for Injection supported by Onyx Pharmaceuticals
(non-CME certified activity) |
|
8:15 am - 9:00 am |
|
Welcome, Introductions, and Opening Remarks
Conference Co-Chairs - Craig Deligdish, MD; Gary Owens, MD; Burt Zweigenhaft, BS |
|
9:00 am - 10:15 am |
|
Session 1: Managed Markets and Perspective on Today and the Future of Value-Based Cancer Care
Burt Zweigenhaft, BS (Moderator);James Lang, PharmD; Jennifer Malin, MD, PhD |
|
10:15 am - 10:30 am |
Break |
||
10:30 am - 11:45 am |
|
Session 2: Trends in Cancer Treatment Decision-Making: Pathways, Personalized Medicine, and Stakeholder Collaborations |
|
12:00 pm - 1:00 pm |
|
Lunch/Product Theater - ABRAXANE in Combination with Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer supported by Celgene Corporation
(non-CME certified activity) |
|
1:15 pm - 2:00 pm |
|
Session 3: Cost of a Cure: When, How, and How Much?
Burt Zweigenhaft, BS (Moderator); John Fox, MD; John Hennessy, CMPE |
|
2:00 pm - 2:45 pm |
|
Session 4: Where is Oncology Care Headed in the Future? |
|
2:45 pm - 3:30 pm |
Session 5: How Will the Oncology Delivery System Change in the Future?
Craig Deligdish, MD (Moderator); Karen Fields, MD; Ted Okon, BS, MBA; John D. Sprandio, MD |
||
3:30 pm - 3:45 pm |
Break |
||
3:45 pm - 4:30 pm |
|
Session 6: Employers and Oncology Care
F. Randy Vogenberg, PhD, RPh (Moderator); Bridget Eber, PharmD; Patricia Goldsmith; Peter Hayes |
|
4:30 pm - 5:15 pm |
|
Session 7: The Role of Government in the Future of Oncology Care
Craig Deligdish, MD (Moderator); Scott Gottlieb, MD; Jayson Slotnick, JD, MPH |
|
5:15 pm - 5:45 pm |
Summary of Day 1
Gary Owens, MD |
||
6:00 pm - 8:00 pm |
Cocktail Reception in the Exhibit Hall |
||
Saturday, May 4, 2013 |
||
7:00 am - 8:00 am |
|
Breakfast/Product Theater - Immunotherapy for the Treatment of Advanced Prostate Cancer supported by Dendreon
(non-CME certified activity) |
8:15 am - 8:30 am |
|
Opening Remarks
Gary Owens, MD |
8:30 am - 9:15 am |
Session 8: Advanced Care Directives: Palliative Care, Hospice, Ethics |
|
9:15 am - 10:00 am |
|
Session 9: Healthcare Delivery Review: A Focus on Medicaid and Health Insurance Exchanges |
10:00 am - 10:30 am |
Session 10: ASCO 2013 Update
Sandra Swain, MD, FACP |
|
10:30 am - 11:15 am |
Session 11: Payer, Government, and Industry Insights: Balancing Cost and Quality
Gary Owens, MD (Moderator); Michael Dubroff, DO; Grant Lawless, MD, RPh, FACP; Kip Piper, MA, FACHE |
|
11:15 am - 12:00 pm |
Session 12: Conquering Patient Issues Associated with Medication Nonadherence |
|
12:15 pm - 1:15 pm |
Lunch/Product Theater - VELCADE® (bortezomib) for Multiple Myeloma: The Continuum of Care supported by Millennium Pharmaceuticals, Inc.
(non-CME certified activity) |
|
1:15 pm - 3:30 pm |
Meet the Experts Networking Roundtable Session (non-CME certified activity)
Topics to include: The 340B Program - Coming to your community of not?, ACO's Impact on the Delivery of Cancer Care, Rationing High Cost Treatments - Who will be the gatekeeper?, Outsourcing Oncology HUB and Pharmacy Distribution Solutions - successes, issues, and challenges, Limited Distribution Models in Oncology - Brown Bagging and White Bagging, Patient Assistance Programs, Hospital Physician Integration, Oncology Medical Homes, Government Assistance Programs, and Diagnostics and Targeted Medicine |
|
3:30 pm - 4:15 pm |
Session 13: Personalized Medicine, Companion Diagnostics, Molecular Profiling, Genomic Sequencing: The Impact on Cost, Treatment, and the Value Proposition
Craig Deligdish, MD (Moderator); Mark S. Boguski, MD, PhD; Gary Palmer, MD, JD, MBA, MPH |
|
4:15 pm - 4:45 pm |
Session 14: Zitter and IMS Trends and Updates in Oncology
Burt Zweigenhaft, BS (Moderator); Douglas M. Long; Pamela Morris |
|
4:45 pm - 5:00 pm |
Summary of Day 2
Gary Owens, MD |
|
5:00 pm - 7:00 pm |
Cocktail Reception in the Exhibit Hall |
|
Sunday, May 5, 2013 |
||
7:00 am - 8:00 am |
|
Breakfast/Product Theater - Pomalyst® : Overview of Prescribing Information supported by Celgene Corporation
(non-CME certified activity) |
8:15 am - 8:30 am |
|
Opening Remarks
Gary Owens, MD |
8:30 am - 9:15 am |
Session 15: Cancer Rehabilitation: The Next Frontier in Survivorship Care |
|
9:15 am - 10:00 am |
Session 16: Current and Future Considerations for the Oncology Practice Manager |
|
10:00 am - 10:15 am |
|
Break |
10:15 am - 11:00 am |
|
Session 17: Access to Drugs - Shortages, Biosimilars
Craig Deligdish, MD (Moderator); Douglas Burgoyne, PharmD; James T. Kenney Jr., RPh, MBA |
11:00 am - 11:45 am |
Session 18: Perspectives from Oncology Group Practices - Successes, Issues, and Challenges Craig Deligdish, MD (Moderator); David Eagle, MD; Thomas Marsland, MD, MHA |
|
11:45 am - 12:00 pm |
Summary and Conclusion of Conference
Gary Owens, MD |
|
*Agenda is subject to change